126 related articles for article (PubMed ID: 27499321)
1. Primary malignant fibrous histiocytoma of long bones: long-term follow-up.
Özkurt B; Başarır K; Yıldız YH; Kalem M; Sağlık Y
Eklem Hastalik Cerrahisi; 2016 Aug; 27(2):94-9. PubMed ID: 27499321
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic factors in patients with malignant fibrous histiocytoma of the extremities].
Atalar H; Başarir K; Yildiz Y; Sağlik Y
Acta Orthop Traumatol Turc; 2007; 41(4):271-6. PubMed ID: 18180555
[TBL] [Abstract][Full Text] [Related]
3. En bloc resection and prosthesis implantation to treat malignant fibrous histiocytoma of the humerus.
Sun J; Zhang RM; Zheng YX
Adv Clin Exp Med; 2017 Aug; 26(5):781-787. PubMed ID: 29068573
[TBL] [Abstract][Full Text] [Related]
4. [An analysis of prognostic factors for malignant fibrous histiocytoma of bone].
Li GX; Guo W; Yang RL; Qu HY; Tang S; Qi DW
Zhonghua Wai Ke Za Zhi; 2011 Aug; 49(8):733-6. PubMed ID: 22168940
[TBL] [Abstract][Full Text] [Related]
5. The Outcome of Patients With Localized Undifferentiated Pleomorphic Sarcoma of the Lower Extremity Treated at Stanford University.
Kamat NV; Million L; Yao DH; Donaldson SS; Mohler DG; van de Rijn M; Avedian RS; Kapp DS; Ganjoo KN
Am J Clin Oncol; 2019 Feb; 42(2):166-171. PubMed ID: 30557163
[TBL] [Abstract][Full Text] [Related]
6. Malignant fibrous histiocytoma of the head and neck: a case series.
Hardison SA; Davis PL; Browne JD
Am J Otolaryngol; 2013; 34(1):10-5. PubMed ID: 22999710
[TBL] [Abstract][Full Text] [Related]
7. Oncological outcome of patients with deeply located soft tissue sarcoma of the pelvis: a follow up study at minimum 5 years after diagnosis.
Nakamura T; Abudu A; Murata H; Grimer RJ; Carter SR; Tillman RM; Jeys L
Eur J Surg Oncol; 2013 Sep; 39(9):1030-5. PubMed ID: 23347778
[TBL] [Abstract][Full Text] [Related]
8. Dedifferentiated central chondrosarcoma.
Staals EL; Bacchini P; Bertoni F
Cancer; 2006 Jun; 106(12):2682-91. PubMed ID: 16691621
[TBL] [Abstract][Full Text] [Related]
9. Primary chemotherapy and delayed surgery for malignant fibrous histiocytoma of bone in the extremity.
Bacci G; Avella M; Picci P; Dallari D; Malaguti C; Biagini R; Ruggieri P; Balladelli A; Ferrari S; Caldora P
Tumori; 1990 Dec; 76(6):537-42. PubMed ID: 2178284
[TBL] [Abstract][Full Text] [Related]
10. Pathologic fracture does not influence prognosis in stage IIB osteosarcoma: a case-control study.
Zuo D; Zheng L; Sun W; Hua Y; Cai Z
World J Surg Oncol; 2013 Jun; 11():148. PubMed ID: 23799947
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant radiotherapy for pediatric and young adult nonrhabdomyosarcoma soft-tissue sarcoma.
Smith KB; Indelicato DJ; Knapik JA; Lagmay JP; Morris C; Kirwan JM; Zlotecki RA; Scarborough MT; Gibbs CP; Marcus RB
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):150-7. PubMed ID: 21550181
[TBL] [Abstract][Full Text] [Related]
12. [Locally recurrent malignant fibrous histiocytoma of the kidney and spermatic cord].
May M; Marusch F; Helke C; Gunia S; Gastinger I; Hoschke B
Urologe A; 2004 Aug; 43(8):976-81. PubMed ID: 15197446
[TBL] [Abstract][Full Text] [Related]
13. Predicting the prognosis of undifferentiated pleomorphic soft tissue sarcoma: a 20-year experience of 266 cases.
Vodanovich DA; Spelman T; May D; Slavin J; Choong PFM
ANZ J Surg; 2019 Sep; 89(9):1045-1050. PubMed ID: 31364245
[TBL] [Abstract][Full Text] [Related]
14. Pathologic fracture does not influence local recurrence and survival in high-grade extremity osteosarcoma with adequate surgical margins.
Xie L; Guo W; Li Y; Ji T; Sun X
J Surg Oncol; 2012 Dec; 106(7):820-5. PubMed ID: 22740310
[TBL] [Abstract][Full Text] [Related]
15. [The effects of surgical margins on local control and survival in extremity soft tissue sarcomas].
Yildiz C; Erler K; Bilgiç S; Ateşalp AS; Başbozkurt M
Acta Orthop Traumatol Turc; 2003; 37(5):359-67. PubMed ID: 14963391
[TBL] [Abstract][Full Text] [Related]
16. Malignant fibrous histiocytoma of bone: A survival analysis from the National Cancer Database.
Malik AT; Baek J; Alexander JH; Voskuil RT; Khan SN; Scharschmidt TJ
J Surg Oncol; 2020 Jun; 121(7):1097-1103. PubMed ID: 32133661
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of therapeutic strategies and prognostic factors of malignant fibrous histiocytoma of soft tissue].
Li GX; Guo W
Zhonghua Wai Ke Za Zhi; 2011 Nov; 49(11):974-7. PubMed ID: 22333415
[TBL] [Abstract][Full Text] [Related]
18. Why do patients with low-grade soft tissue sarcoma die?
Canter RJ; Qin LX; Ferrone CR; Maki RG; Singer S; Brennan MF
Ann Surg Oncol; 2008 Dec; 15(12):3550-60. PubMed ID: 18830667
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment and prognosis in patients with high-grade soft tissue malignant fibrous histiocytoma of the extremities.
Vasileios KA; Eward WC; Brigman BE
Arch Orthop Trauma Surg; 2012 Jul; 132(7):955-61. PubMed ID: 22487849
[TBL] [Abstract][Full Text] [Related]
20. The value of high-dose methotrexate-based neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone.
Ham SJ; Hoekstra HJ; van der Graaf WT; Kamps WA; Molenaar WM; Schraffordt Koops H
J Clin Oncol; 1996 Feb; 14(2):490-6. PubMed ID: 8636762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
